limit tamoxifen (Nolvadex) use to 5 years

The National Cancer Institute is now alerting oncologists to limit tamoxifen (Nolvadex) use to 5 years...for certain women being treated for early-stage breast cancer.

This announcement refers specifically to women with node-negative, estrogen receptor-positive breast cancers.

Taking tamoxifen for 5 years after lumpectomy or mastectomy significantly reduces the risk of recurrence and improves survival.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote